A detailed history of D. E. Shaw & Co., Inc. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 582,858 shares of DSGN stock, worth $3.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
582,858
Holding current value
$3.7 Million
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.19 - $5.88 $150,166 - $276,795
47,074 Added 8.79%
582,858 $3.14 Million
Q2 2024

Aug 14, 2024

BUY
$3.23 - $4.77 $289,388 - $427,363
89,594 Added 20.08%
535,784 $1.79 Million
Q1 2024

May 15, 2024

BUY
$2.27 - $4.03 $353,125 - $626,914
155,562 Added 53.53%
446,190 $1.8 Million
Q4 2023

Feb 14, 2024

BUY
$1.99 - $2.76 $554,987 - $769,730
278,888 Added 2375.54%
290,628 $770,000
Q3 2023

Nov 14, 2023

SELL
$2.05 - $8.14 $253,256 - $1.01 Million
-123,540 Reduced 91.32%
11,740 $27,000
Q2 2023

Aug 14, 2023

BUY
$4.99 - $7.64 $119,670 - $183,222
23,982 Added 21.55%
135,280 $852,000
Q1 2023

May 15, 2023

BUY
$5.5 - $9.77 $612,139 - $1.09 Million
111,298 New
111,298 $642,000

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $354M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.